Medical Polyetheretherketone Market is anticipated to reach a valuation of US$ 1158.26 Million by 2032 | FMI

 The global Medical Polyetheretherketone Market is expected to reach a market valuation of US$ 572.54 Million by 2022, accelerating with a moderate CAGR of 7.3% by 2022-2032. The medical polyetheretherketone market size is anticipated to be valued at about US$ 1158.26 Million by 2032 end.

Increased adoption of medical polyetheretherketone as a substitute for metals has boosted the medical polyetheretherketone market. Aluminum, carbon steel, bronze, stainless steel, brass, titanium, and magnesium are among the metals that medical polyetheretherketone has begun to replace in significant numbers.

Gain complete access to the report @ https://www.futuremarketinsights.com/reports/medical-polyetheretherketone-market

As a result of rigorous environmental rules, automakers are compelled to increase fuel economy, decrease maintenance needs, and lower noise levels. As a result of these laws, the trend for lighter automobiles is being driven by automobile light-weighting. Polyetheretherketone is a substantial improvement over metals for decreasing pollutants and increasing fuel efficiency.

The demand for medical polyetheretherketone will not grow as fast as it could because it is more expensive than other medical-grade polymers. But these plastics can't replace medical polyetheretherketone because it is a high-performance polymer with better qualities like high flexural strength, resistance to impact, resistance to chemicals and heat, and compatibility with living organisms. Strict rules about medical devices also make it hard to use medical polyetheretherketone in medical devices and implants.

Over the projection period, the Asia-Pacific region's revenue is anticipated to increase by 8.7 per cent. With a medical polyetheretherketone market value of USD 36.17 million in APAC for medical polyetheretherketone in 2021, cardiovascular applications emerged as the leading category in the region. This is due to the sedentary lifestyles of the young and old in nations such as China and India.

To satisfy the rising demand for dental implants and dentures in the region, it is anticipated that the adoption of medical polyetheretherketone denture base material will increase. As a result, in the Asia-Pacific area, dental implants and fixtures are anticipated to increase at a 9.3 per cent CAGR over the projection period.

Biocompatible Polyetheretherketone is emerging as an eco-friendly alternative in a variety of applications. Compared to other polymers, such as ABS, polyester laminate, polyvinyl chloride, polystyrene, and polysulphone, its use results in lower carbon emissions. By providing exceptional corrosion resistance, PEEK extends the service life of the goods in which it is utilised. It can also operate at elevated temperatures for a longer duration than other polymers. It is one of the most adaptable products in terms of production design flexibility, resulting in minimal labour dependence. The substantial benefits are leading the demand for medical polyetheretherketone.

Key Takeaways from Market Study

  • In 2021, the spine implantation segment led the medical polyetheretherketone market and contributed for more than 30.0% of global revenue.
  • North America held the biggest medical polyetheretherketone market share in 2021, at over 40 percent, and is anticipated to experience substantial increase throughout the forecast period.
  • In Canada, sales of medical polyetheretherketone are anticipated to expand at a CAGR of around 7% during the coming year. Both the commercial and public sectors are making substantial investments in Canada's healthcare industry, which is fuelling research and development.
  • There are currently 54 million Americans over the age of 65, and this number is predicted to rise to 74 million by 2030. The elderly population, which requires the most comprehensive care, is growing even more fast. The region's substantial elderly population is also driving growth in the medical polyetheretherketone industry.

Competitive Landscape

Due to a few regional players, the global demand for medical polyetheretherketone is consolidated. Important participants include Panjin Zhongrun High-Performance Polymers Co. Ltd., Victrex Plc., Jrlon Inc., and Quadrant EPP Surlon India Ltd.

Increasing overall applicability in a range of areas, such as medical, aerospace, and automotive, has led to the expansion of the industrial service provider market and thus also changing the medical polyetheretherketone market outlook. Prototype & Plastic Mold Co. Inc., Parkway Products Inc., A. Schulman AG, and Stern Sectors Inc. are among the key service providers that use the product for injection moulding and other uses in a variety of industries.

Global Medical Polyetheretherketone Market Key Players

  • Superior Polymers
  • Evonik Industries AG
  • Invibio Ltd.
  • Solvay
  • Medtronic

Medical Polyetheretherketone Market by Segmentation

By Application:

  • Trauma Fixation
  • Cardiovascular
  • Orthopaedic
    • Spine Implantation
    • Knee & Hip Implantation
  • Dental Implants & Fixtures
  • Others

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Primary Sclerosing Cholangitis (PSC) Market Size, Opportunities and Forecast 2023-2033

Image
  The global Primary Sclerosing Cholangitis (PSC) Market is anticipated to be worth US$ 151.07 million in 2023.  Primary Sclerosing Cholangitis (PSC) With growing alcohol consumption, the worldwide market for Primary Sclerosing Cholangitis (PSC) is expected to develop at a CAGR of 7.6% between 2023 and 2033, totaling roughly US$ 314.26 Million by 2033. According to the analysis of Future Market Insights, the Primary Sclerosing Cholangitis (PSC) market is expected to fuel over the analysis period, attributed to the factors such as the rise in the incidences of liver diseases, as well as rise in alcohol consumption. Get Full Access @ https://www.futuremarketinsights.com/reports/primary-sclerosing-cholangitis-psc-market  As per the Centers for Disease Control and Prevention, the global incidence of liver disease was 3.9 million in 2016. As per the World Health Organization (WHO), prevalence of liver cirrhosis is increasing in the European countries, due to high con...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more